At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MSB Mesabi
Market Closed 06-18 16:00:00 EDT
24.78
+0.06
+0.24%
盘后24.78
+0.000.00%
16:10 EDT
High25.31Low24.67Vol40.07K
Open24.80D1 Closing24.72Amplitude2.58%
Mkt Cap325.11MTradable Cap324.86MTotal Shares13.12M
T/O999.04KT/O Rate0.31%Tradable Shares13.11M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Mesoblast (ASX:MSB) Is Up 9.2% After Ryoncil’s Near-US$100m Debut And Revascor FDA Progress – Has The Bull Case Changed?
Simply Wall St.  ·  06-21 00:29
Mesoblast (ASX:MSB) Is Up 9.2% After Ryoncil’s Near-US$100m Debut And Revascor FDA Progress – Has The Bull Case Changed?
Mesabi Trust Q1 FY27 net income drops 70.05% to $1.09 million
Reuters  ·  06-13
Mesabi Trust Q1 FY27 net income drops 70.05% to $1.09 million
Press Release: Mesabi Metallics Monetizes Portion of Royalty Interest for $265 Million
Dow Jones  ·  06-02
Press Release: Mesabi Metallics Monetizes Portion of Royalty Interest for $265 Million
The Metals Royalty Company Inc. Closes Mesabi Royalty Acquisition, Exercises Option to Acquire an Additional 1% Royalty Interest and Appoints Michael Hess as Non-Executive Co-Chairman
TIPRANKS  ·  06-02
The Metals Royalty Company Inc. Closes Mesabi Royalty Acquisition, Exercises Option to Acquire an Additional 1% Royalty Interest and Appoints Michael Hess as Non-Executive Co-Chairman
The Metals Royalty Company Acquires Mesabi Royalty; Names Michael Hess as Non-Executive Co-Chairman
MT Newswires Live  ·  06-02
The Metals Royalty Company Acquires Mesabi Royalty; Names Michael Hess as Non-Executive Co-Chairman
Assessing Mesoblast (ASX:MSB) Valuation After Phase 3 Recruitment Milestone For Rexlemestrocel L
Simply Wall St.  ·  05-07
Assessing Mesoblast (ASX:MSB) Valuation After Phase 3 Recruitment Milestone For Rexlemestrocel L
Mesabi Trust Reports Higher Shipments But No Bonus Royalties
TIPRANKS  ·  05-05
Mesabi Trust Reports Higher Shipments But No Bonus Royalties
Is Completing Phase 3 Enrollment For Rexlemestrocel-L Reshaping The Investment Case For Mesoblast (ASX:MSB)?
Simply Wall St.  ·  05-02
Is Completing Phase 3 Enrollment For Rexlemestrocel-L Reshaping The Investment Case For Mesoblast (ASX:MSB)?
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
GlobeNewswire  ·  04-29
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
Mesabi Trust (MSB) Q3 Net Margin Strengthens Bearish Dividend Coverage Narratives
Simply Wall St.  ·  04-24
Mesabi Trust (MSB) Q3 Net Margin Strengthens Bearish Dividend Coverage Narratives
Mesabi Trust publishes fiscal 2026 annual report
Reuters  ·  04-23
Mesabi Trust publishes fiscal 2026 annual report
Mesoblast (ASX:MSB) Is Up 6.1% After FDA Clears Registrational DMD Trial for Ryoncil
Simply Wall St.  ·  04-19
Mesoblast (ASX:MSB) Is Up 6.1% After FDA Clears Registrational DMD Trial for Ryoncil
Mesoblast (ASX:MSB) Valuation Check As New CAR Technology License Targets Stronger Cell Therapy Pipeline
Simply Wall St.  ·  04-16
Mesoblast (ASX:MSB) Valuation Check As New CAR Technology License Targets Stronger Cell Therapy Pipeline
Press Release: Mesabi Trust Press Release
Dow Jones  ·  04-15
Press Release: Mesabi Trust Press Release
Did FDA-Cleared Duchenne Trial for Ryoncil Just Shift Mesoblast's (ASX:MSB) Investment Narrative?
Simply Wall St.  ·  04-12
Did FDA-Cleared Duchenne Trial for Ryoncil Just Shift Mesoblast's (ASX:MSB) Investment Narrative?
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
GlobeNewswire  ·  04-11
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation
GlobeNewswire  ·  04-08
Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation
Is Mesoblast (ASX:MSB) Offering Value After Recent Share Price Declines?
Simply Wall St.  ·  04-08
Is Mesoblast (ASX:MSB) Offering Value After Recent Share Price Declines?
Macquarie Group Rise After Financing Mesabi's Minnesota Iron Ore Mine
MT Newswires Live  ·  04-07
Macquarie Group Rise After Financing Mesabi's Minnesota Iron Ore Mine
Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter
GlobeNewswire  ·  04-07
Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter

Introduction

Company Name.
Mesabi
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. Mesabi Trust was founded in 1961 and is based in New York, New York.
Issue price:
--